Literature DB >> 24930888

The hypocretin/orexin system mediates the extinction of fear memories.

África Flores1, Victòria Valls-Comamala1, Giulia Costa2, Rocío Saravia1, Rafael Maldonado1, Fernando Berrendero1.   

Abstract

Anxiety disorders are often associated with an inability to extinguish learned fear responses. The hypocretin/orexin system is involved in the regulation of emotional states and could also participate in the consolidation and extinction of aversive memories. Using hypocretin receptor-1 and hypocretin receptor-2 antagonists, hypocretin-1 and hypocretin-2 peptides, and hypocretin receptor-1 knockout mice, we investigated the role of the hypocretin system in cue- and context-dependent fear conditioning and extinction. Hypocretins were crucial for the consolidation of fear conditioning, and this effect was mainly observed in memories with a high emotional component. Notably, after the acquisition of fear memory, hypocretin receptor-1 blockade facilitated fear extinction, whereas hypocretin-1 administration impaired this extinction process. The extinction-facilitating effects of the hypocretin receptor-1 antagonist SB334867 were associated with increased expression of cFos in the basolateral amygdala and the infralimbic cortex. Intra-amygdala, but neither intra-infralimbic prefrontal cortex nor intra-dorsohippocampal infusion of SB334867 enhanced fear extinction. These results reveal a key role for hypocretins in the extinction of aversive memories and suggest that hypocretin receptor-1 blockade could represent a novel therapeutic target for the treatment of diseases associated with inappropriate retention of fear, such as post-traumatic stress disorder and phobias.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24930888      PMCID: PMC4200503          DOI: 10.1038/npp.2014.146

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  49 in total

1.  Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal.

Authors:  Ainhoa Plaza-Zabala; África Flores; Rafael Maldonado; Fernando Berrendero
Journal:  Biol Psychiatry       Date:  2011-08-10       Impact factor: 13.382

2.  Switching on and off fear by distinct neuronal circuits.

Authors:  Cyril Herry; Stephane Ciocchi; Verena Senn; Lynda Demmou; Christian Müller; Andreas Lüthi
Journal:  Nature       Date:  2008-07-09       Impact factor: 49.962

Review 3.  Neuronal circuits of fear extinction.

Authors:  Cyril Herry; Francesco Ferraguti; Nicolas Singewald; Johannes J Letzkus; Ingrid Ehrlich; Andreas Lüthi
Journal:  Eur J Neurosci       Date:  2010-02-11       Impact factor: 3.386

Review 4.  Fear conditioning and extinction: emotional states encoded by distinct signaling pathways.

Authors:  Natalie C Tronson; Kevin A Corcoran; Vladimir Jovasevic; Jelena Radulovic
Journal:  Trends Neurosci       Date:  2011-11-25       Impact factor: 13.837

5.  Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.

Authors:  Ainhoa Plaza-Zabala; Elena Martín-García; Luis de Lecea; Rafael Maldonado; Fernando Berrendero
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

6.  Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation.

Authors:  Shingo Soya; Hirotaka Shoji; Emi Hasegawa; Mari Hondo; Tsuyoshi Miyakawa; Masashi Yanagisawa; Michihiro Mieda; Takeshi Sakurai
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

7.  Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes.

Authors:  Marguerite C Camp; Kathryn P Macpherson; Lauren Lederle; Carolyn Graybeal; Stefano Gaburro; Lauren M Debrouse; Jessica L Ihne; Javier A Bravo; Richard M O'Connor; Stephane Ciocchi; Cara L Wellman; Andreas Lüthi; John F Cryan; Nicolas Singewald; Andrew Holmes
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

8.  Projections of the paraventricular and paratenial nuclei of the dorsal midline thalamus in the rat.

Authors:  Robert P Vertes; Walter B Hoover
Journal:  J Comp Neurol       Date:  2008-05-10       Impact factor: 3.215

9.  Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant.

Authors:  Hendrik Dietrich; François Jenck
Journal:  Psychopharmacology (Berl)       Date:  2010-07-15       Impact factor: 4.530

10.  Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain.

Authors:  Kathryn Hefner; Nigel Whittle; Jaynann Juhasz; Maxine Norcross; Rose-Marie Karlsson; Lisa M Saksida; Timothy J Bussey; Nicolas Singewald; Andrew Holmes
Journal:  J Neurosci       Date:  2008-08-06       Impact factor: 6.167

View more
  48 in total

1.  Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression.

Authors:  Clarissa D Staton; Jazmine D W Yaeger; Delan Khalid; Fadi Haroun; Belissa S Fernandez; Jessica S Fernandez; Bali K Summers; Tangi R Summers; Monica Sathyanesan; Samuel S Newton; Cliff H Summers
Journal:  Neuropharmacology       Date:  2018-09-18       Impact factor: 5.250

2.  Orexin neuropeptides contribute to the development and persistence of generalized avoidance behavior in the rat.

Authors:  Daniele Viviani; Patrizia Haegler; Francois Jenck; Michel A Steiner
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

3.  Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.

Authors:  Carla Ramon-Duaso; Thomas Gener; Marta Consegal; Cristina Fernández-Avilés; Juan José Gallego; Laura Castarlenas; Maurice S Swanson; Rafael de la Torre; Rafael Maldonado; M Victoria Puig; Patricia Robledo
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

4.  An alerting structure: human orexin receptor 1.

Authors:  Daniel Wacker; Bryan L Roth
Journal:  Nat Struct Mol Biol       Date:  2016-04       Impact factor: 15.369

5.  Activation of orexin/hypocretin neurons is associated with individual differences in cued fear extinction.

Authors:  Amanda C Sharko; Jim R Fadel; Kris F Kaigler; Marlene A Wilson
Journal:  Physiol Behav       Date:  2016-10-13

6.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

7.  Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).

Authors:  Coleman B Calva; Habiba Fayyaz; Jim R Fadel
Journal:  J Neurochem       Date:  2018-01-12       Impact factor: 5.372

8.  Excitation of Cortical nNOS/NK1R Neurons by Hypocretin 1 is Independent of Sleep Homeostasis.

Authors:  Rhîannan H Williams; Sarah W Black; Alexia M Thomas; Juliette Piquet; Bruno Cauli; Thomas S Kilduff
Journal:  Cereb Cortex       Date:  2019-03-01       Impact factor: 5.357

Review 9.  The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.

Authors:  David E Moorman
Journal:  Psychopharmacology (Berl)       Date:  2018-03-06       Impact factor: 4.530

10.  OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.

Authors:  Philip L Johnson; Lauren M Federici; Stephanie D Fitz; John J Renger; Brock Shireman; Christopher J Winrow; Pascal Bonaventure; Anantha Shekhar
Journal:  Depress Anxiety       Date:  2015-08-19       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.